Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals
Patients & Caregivers
Medical resources to keep you educated and informed
Healthcare Professionals
Your Direct Line to Merck Resources
Products
Our medicines and vaccines
Merck Vaccines.com-Opens new window
Merck Authorized Distributors
Merck Pipeline

Privacy Policy
A summary of the company's research pipeline - Opens new window
In these challenging times, Merck is here to help - Opens new window Merck programs to help those in need

News
NYSE | MRK 24.4000 | +0.8400 4:02 PM ET | 21 Nov 2008
Product News
Read the latest news on Merck medicines and vaccines
Research & Development News
Read the latest news on Merck Research and Development
Corporate News
Merck Reaffirms Cardiovascular Research Commitment
Financial News
Merck Announces Voluntary Delisting from Philadelphia Stock Exchange
Corporate Responsibility
Public Health Officials Announce Progress in Elimination of Transmission Of the Tropical Disease River Blindness

Focus On
Corporate Responsibility
New! Read our latest corporate responsibility report
GARDASIL®
Merck Responds to Questions about Adverse Events Reported
SINGULAIR® (montelukast)
Statement: FDA early communication on safety review of SINGULAIR
FOSAMAX® (alendronate sodium)
Statement regarding Osteonecrosis of the Jaw
VIOXX Information Center
Information on the voluntary withdrawal of VIOXX® (rofecoxib)
This U.S. Web site is subject to Merck.com Terms of Use RSS RSS    PODCAST Podcast
Contact Merck Site Map Privacy Policy Opens new window Terms of Use Copyright 1995-2008 Merck & Co., Inc.